scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1012720322 |
P356 | DOI | 10.1007/S00774-012-0394-9 |
P698 | PubMed publication ID | 23192248 |
P50 | author | Robby Engelmann | Q62072585 |
P2093 | author name string | Johannes Keller | |
Bernhard Frerich | |||
Brigitte Müller-Hilke | |||
Robert P Marshall | |||
Sarah Joost | |||
Juliane Pasold | |||
P2860 | cites work | RANK is essential for osteoclast and lymph node development | Q24598872 |
Targeted disruption of the Cl-/HCO3- exchanger Ae2 results in osteopetrosis in mice | Q24658114 | ||
Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans | Q24673342 | ||
Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis | Q28143618 | ||
Skeletal remodeling in health and disease | Q28235713 | ||
The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice | Q28508070 | ||
Bone defects in latent TGF-beta binding protein (Ltbp)-3 null mice; a role for Ltbp in TGF-beta presentation | Q28593249 | ||
Osteoclast differentiation and activation | Q29547556 | ||
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee | Q29616160 | ||
Genetic regulation of osteoclast development and function | Q29617421 | ||
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2. | Q33570529 | ||
Effects of risedronate on osteoarthritis of the knee | Q33670485 | ||
Genetic disorders of the skeleton: a developmental approach | Q33906292 | ||
Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence | Q34573852 | ||
PPAR-gamma regulates osteoclastogenesis in mice | Q34585778 | ||
The role of bone metabolism in osteoarthritis | Q35067936 | ||
Sexual dimorphism in the osteoarthritis of STR/ort mice may be linked to articular cytokines | Q35552193 | ||
Osteoarthritis and osteoporosis in postmenopausal women: clinical similarities and differences | Q35951382 | ||
The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts | Q36268888 | ||
Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis | Q36273884 | ||
Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice | Q36791739 | ||
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. | Q36927212 | ||
Hematopoietic stem cell transplantation for osteopetrosis | Q37716133 | ||
Heritable sclerosing bone disorders: presentation and new molecular mechanisms | Q37730937 | ||
Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse | Q41205540 | ||
Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. | Q41689026 | ||
OSTM1 bone defect reveals an intercellular hematopoietic crosstalk. | Q41866199 | ||
High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes | Q42262347 | ||
Inhibition of bone resorption blunts osteoarthritis in mice with high bone remodelling. | Q43043830 | ||
Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation | Q45182791 | ||
Differential age-related bone architecture changes between female and male STR/Ort mice. | Q51363839 | ||
Mechanisms of osteoclast dysfunction in human osteopetrosis: abnormal osteoclastogenesis and lack of osteoclast-specific adhesion structures. | Q54066965 | ||
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
Degenerative joint disease in the mouse knee; histological observations | Q67043967 | ||
The relationship of bone density and fracture to incident and progressive radiographic osteoarthritis of the knee: the Chingford Study | Q77567471 | ||
Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis | Q80398194 | ||
Phenotypic characteristics of bone in carbonic anhydrase II-deficient mice | Q80444950 | ||
The genetics of osteoarthritis in STR/ort mice | Q81431142 | ||
Revealing the interplay of bone and cartilage in osteoarthritis through multimodal imaging of murine joints | Q83950072 | ||
P433 | issue | 1 | |
P921 | main subject | hemopoiesis | Q919283 |
P304 | page(s) | 71-81 | |
P577 | publication date | 2012-11-29 | |
P1433 | published in | Journal of Bone and Mineral Metabolism | Q15767236 |
P1476 | title | High bone mass in the STR/ort mouse results from increased bone formation and impaired bone resorption and is associated with extramedullary hematopoiesis | |
P478 | volume | 31 |
Q51832902 | Allogeneic yet major histocompatibility complex-matched bone marrow transplantation in mice results in an impairment of osteoblasts and a significantly reduced trabecular bone. |
Q58758365 | Comparative Transcriptomics Identifies Novel Genes and Pathways Involved in Post-Traumatic Osteoarthritis Development and Progression |
Q91015246 | Inhibition of cyclooxygenase-2 activity in subchondral bone modifies a subtype of osteoarthritis |
Q55230718 | Sexually dimorphic tibia shape is linked to natural osteoarthritis in STR/Ort mice. |
Q37708031 | Sprint Interval Training Induces A Sexual Dimorphism but does not Improve Peak Bone Mass in Young and Healthy Mice |
Q41634814 | Stable sulforaphane protects against gait anomalies and modifies bone microarchitecture in the spontaneous STR/Ort model of osteoarthritis |
Q28075993 | The STR/ort mouse model of spontaneous osteoarthritis - an update |
Q47549333 | Young and healthy C57BL/6 J mice performing sprint interval training reveal gender- and site-specific changes to the cortical bone. |